Mackenzie Financial’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Mackenzie Financial’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,363,697	Closed	-$69.6M	–	1833
2024 Q4	$69.6M	Buy	1,363,697 +509,868	+60%	+$25.1M	0.09%	180
2024 Q3	$35.2M	Buy	+853,829	New	+$41M	0.05%	263
2023 Q2	–	Sell	-8,552	Closed	-$528K	–	1664
2023 Q1	$528K	Buy	+8,552	New	+$513K	﹤0.01%	1012
2022 Q4	–	Sell	-3,176	Closed	-$231K	–	1603
2022 Q3	$231K	Sell	3,176 -111	-3%	-$8.26K	﹤0.01%	1188
2022 Q2	$223K	Buy	+3,287	New	+$236K	﹤0.01%	1235

Other funds holding NARI

SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Mackenzie Financial's NARI Position: Q1 2025 in Review

Mackenzie Financial sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 1,363,697 shares — an estimated $69.6M sold.

Mackenzie Financial first reported a position in NARI in Q2 2022 and held it in 5 quarters. The position peaked at $69.6M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

Mackenzie Financial reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Mackenzie Financial sold 1,363,697 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $69.6M.
Mackenzie Financial first reported a position in Inari Medical, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Mackenzie Financial's Inari Medical, Inc. Common Stock position peaked at $69.6M in Q4 2024.
4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Mackenzie Financial's 13F filing for Q1 2025, filed 7 May 2025.